Last reviewed · How we verify

NCT04554758

Comparative Analysis Between Sleeve Gastrectomy and Roux-en Y Gastric Bypass in Bariatric Operation

Status unknown NA Last updated 8 October 2020
What this trial tests

NA trial testing Sleeve gastrectomy in Obesity, Morbid in 400 participants. Status unknown.

Timeline
1 September 2020
Primary endpoint
31 August 2022
31 August 2023

Quick facts

Lead sponsorInha University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment400
Start date1 September 2020
Primary completion31 August 2022
Estimated completion31 August 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Inha University Hospital

Who can join

Adults 20 to 65, any sex, with Obesity, Morbid or Overnutrition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, double-arm, multi-center cohort study on obese patients, for laparoscopic sleeve gastrectomy versus Roux-en Y gastric bypass

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Changes in Trimethylamine-N-oxide Levels in Obese Patients following Laparoscopic Roux-en-Y Gastric Bypass or Sleeve Gastrectomy in a Korean Obesity Surgical Treatment Study (KOBESS).
    Lee SJ, Park YS, Kim YJ, Han SU, et al · · 2021 · cited 8× · PMID 34768610 · DOI 10.3390/jcm10215091

Verify or expand the search:

Other trials of Sleeve gastrectomy

Trials testing the same drug.

Other recruiting trials for Obesity, Morbid

Currently open trials in the same condition.

Other Inha University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04554758.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing